Agenda
Coming Soon
We have a full agenda for both days, details of both the morning and afternoon sessions can be found below.
Day 1 - Deep Venous Therapies
Time
Events
Speakers
- 0800 - 0855
Registration
- 0855 - 0900
Welcome
Miss Kaji Sritharan, York
Management of Acute DVT
Chairs: Dr Marta Ramirez Ortega & Mr Taha Khan
- 0900 - 0910
Cost effectiveness and QALY - is there sufficient evidence to justify Acute and Chronic DVT Interventions in the UK NHS
Prof Marianne Brodmann, Austria
- 0910 - 0920
Update: EVeR Registry and ongoing DVT Trials
Dr Olivier Hartung, France
- 0920 - 0930
Management of Acute DVT – what does best practice look like and how far away are UK units from achieving this?
Mr Sandip Nandhra, Newcastle
- 0930 - 0940
PANEL DISCUSSION
Debate
Chairs – Mr Chung Lim & Mr Taha Khan
- 0930 - 1000
DEBATE: All Centres in the UK should offer DVT Interventions
FOR: Prof Dan Carradice, Hull
AGAINST: Prof Rob Morgan, London
AGAINST: Prof Rob Morgan, London
- 1000 - 1020
Coffee Break
- 1205 - 1220
PANEL DISCUSSION
Management of Acute DVT
Chairs: Dr Andy Wigham & Dr Raj Gali
- 1020 - 1035
Pre-procedure Planning for Acute DVT – My Toolkit and how I Plan for Success
Mr Taha Khan, London
- 1035 - 1050
My approach to Stenting in Acute DVT – tips and tricks
Dr Marta Ramirez Ortega, Spain
- 1050 - 1105
PANEL DISCUSSION
Mechano-thrombectomy Devices in Acute DVT
Chairs: Dr Olivier Hartung & Dr Andy Wigham
- 1105 - 1205
Which tool for which lesion and why? – Case-based Discussion
- Inari ClotTriever
- Aspirex (BD)
- CDT
- Angiojet (Boston)
- Inari ClotTriever
- Aspirex (BD)
- CDT
- Angiojet (Boston)
Miss Emma Wilton, Oxford
Dr Mert Dumantepe, Turkey
Dr Narayanan Thulasidasan London
Prof Efthymios Avgerinos, Greece
- 1205 - 1220
New concepts in the Management of DVT – which anticoagulant / anti-platelet, when and for how long?
Dr Karen Breen, London
- 1220 - 1235
AI in Venous Disease – can it revolutionise diagnosis and treatment in deep venous disease?
Prof Efthymios Avgerinos, Greece
- 1235 - 1250
PANEL DISCUSSION
- 1250 - 1340
Lunch
Time
Events
Speakers
Management of Chronic DVT
Chairs: Miss Emma Wilton & Dr Mohammad Barbati
- 1340 - 1355
Management of Chronic DVT – How to select winners and planning for success
Dr Mohammad Barbati, Germany
- 1355 - 1420
Reconstruction of the IVC – tips and tricks
Dr Andy Wigham, Oxford
- 1420 - 1435
Surveillance post-stenting, preventing stent occlusion and Management of In-stent Restenosis/Thrombosis
Mr Adam Gwozdz, London
- 1435 - 1450
PANEL DISCUSSION
- 1450 - 1510
Coffee
Mixed Cases
Chairs: Prof Efthymios Avgerinos & Dr Karen Breen
- 1510 - 1525
Stenting in the young female – what is the risk of stent occlusion in subsequent pregnancy
Dr Narayanan Thulasidasan, London
- 1525 - 1540
Nutcracker Syndrome – when and how do you treat?
Dr Olivier Hartung, France
- 1525 - 1540
Venous TOS – My Practice & Current Evidence
Dr Mert Dumantepe, Turkey
- 1435 - 1450
PANEL DISCUSSION
Pulmonary Embolism Thrombectomy
Chairs: Prof Rob Morgan & Prof Marianne Brodmann
- 1610 - 1625
Developing a PE Service – Challenges and Opportunities
Dr Conrad von Sempel, London
- 1625 - 1645
My approach to PE Treatment – Options and Strategies
- 1645 - 1700
PANEL DISCUSSION
- 1700 - 1705
Close of Meeting
Miss Kaji Sritharan, Meeting Director
Day 2 - Peripheral Arterial Therapies
Time
Events
Speakers
- 0800 - 0805
Welcome
Miss Kaji Sritharan, LLES Meeting Director
Breakfast Meeting
Research
Chairs: Mr Andy Thompson & Prof Michael Reijnen
- 0805 - 0820
Vascular Research: Trials on the Horizon
Prof Athanasios Saratzis, Leicester
- 0820 - 0835
BASIL-2, BASIL-3 and BEST-CLI – an update
Mr Matt Popplewell, Birmingham
- 0835 - 0845
BASIL-2, BASIL-3 and BEST-CLI – more of the same but does it change practice
Dr Raghuram Lakshminarayan, Hull
- 0845 - 0855
PANEL DISCUSSION
Aorto-Iliac Disease
Chairs: Dr Sapna Puppala & Prof Thomas Zeller
- 0855 - 0910
CERAB – When I do it, Technical Considerations and Long-term Outcomes
Prof Michael Reijnen, Netherlands
- 0910 - 0925
Iliac Disease – are all stents equal?
Dr Willemien van de Water, Netherlands
- 0925 - 0940
IVL as a primary treatment strategy for aorto-iliac disease – When I do it, Technical Considerations and Outcomes
Dr Stefano Fazzini, Italy
- 0940 - 0950
PANEL DISCUSSION
- 0950 - 1010
Coffee
Femoro-popliteal Disease (I)
Chairs: Dr Mariano Palena & Dr Rosie Cadwallader
- 1010 - 1025
My algorithm for treating the Common Femoral Artery: plaque morphology and choice of intervention?
Prof Thomas Zeller, Germany
- 1025 - 1040
1025-1040 Drug-eluting technology – Paclitaxel vs Sirolimus in the SFA - the winners and
losers
Prof Sabine Steiner, Germany
- 1040 - 1050
PANEL DISCUSSION
Femoro-popliteal Disease (II)
Chairs: Dr Konstantinos Stavroulakkis & Dr Andy Wigham
- 1050 - 1105
Which atherectomy / thrombectomy device – the evidence to support their use
Dr Marc Sirvent, Spain
- 1105 - 1120
My approach to Long CTO lesions – my tips for crossing, vessel preparation and stent selection (when needed)
Dr Stavros Spiliopoulos, Greece
- 1120 - 1135
Wire Assisted Remote Endarterectomy (WARE) – a hybrid technique for SFA recanalisation
Mr Ramasubramanyan Chandrasekar, UK
- 1120 - 1135
Wire Assisted Remote Endarterectomy (WARE) – a hybrid technique for SFA recanalisation
Mr Ramasubramanyan Chandrasekar, UK
- 1135 - 1145
PANEL DISCUSSION
Evidence Session (I)
Chairs: Dr Marc Sirvent
- 1145 - 1200
Robotics in Vascular Surgery – the future is closer than we think
Dr Konstantinos Stavroulakkis, Germany
- 1200 - 1215
Can AI Prevent Amputations?
- 1215 - 1225
PANEL DISCUSSION
- 1225 - 1235
Cordis Sponsored Talk
- 1235 - 1330
Lunch
Time
Events
Speakers
Evidence Session (II)
Chairs: Dr Stefano Fazzini & Dr Yann Goeffic
- 1330 - 1340
In-stent re-stenosis – what works?
Mr Prakash Saha, London
- 1340 - 1350
Bioresorbable Vascular Scaffolds – where, when and why?
Prof Athanasios Diamantopoulos, London
- 1350 - 1400
PANEL DISCUSSION
Acute Limb Ischaemia
Chair: Dr Stavros Spiliopoulos & Prof Sabine Steiner
- 1400 - 1415
The Evidence for Mechanical Thrombectomy vs Lysis vs Surgery for Acute Limb
Ischaemia
Prof Yann Gouëffic, France
- 1415 - 1425
Why we need an ALI Trial
Mr Sandip Nandhra, Newcastle
- 1425 - 1435
PANEL DISCUSSION
- 1435 - 1455
Coffee
Evidence Session (III)
Chairs: Prof Athanasios Saratzis & Dr Daniel van den Heuvel
- 1455 - 1510
PAD – are women different?
Prof Marianne Brodmann, Austria
- 1510 - 1525
Variations in Amputations in the UK / Europe – are we getting better at saving legs?
Prof Dave Russell, Leeds
- 1525 - 1540
Bridging the gap between primary and secondary care to save legs
Prof Stella Vig, London
- 1540 - 1550
PANEL DISCUSSION
BTK Disease
Chairs: Dr Raghuram Lakshminarayan & Prof Marianne Brodmann
- 1545 - 1605
My approach to below the knee disease – What works?
Dr Mariano Palena, Italy
- 1605 - 1620
Percutaneous Deep Vein Arterialisation: Off the shelf techniques – how to? And how do they compare to the LimFlow system?
Dr Daniel van den Heuvel, Germany
- 1620 - 1635
Tips and tricks to overcome common pitfalls of calcified CLTI – a Case-based Discussion
Dr Narayanan Thulasidasan, London
- 1635 - 1645
PANEL DISCUSSION
- 1645 - 1650
Close of Meeting
